In vivo removal of radioactive cesium compound using Prussian blue-deposited iron oxide nanoparticles

Hasan Al Faruque, Eun Sook Choi, Jung Hee Kim, Soonhyun Kim, Eunjoo Kim

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Aim: To mitigate the side effects of medical treatment by Prussian blue (PB), a well-known adsorbent for radioactive cesium (Cs), PB-deposited magnetic nanoparticles (MNPs), were prepared and analyzed on the adsorbent capacity for Cs removal. Materials & methods: The PB-deposited MNPs were prepared by photo-deposition method and investigated for their Cs adsorption properties in vitro and in vivo. The distribution of the adsorbents was also evaluated in C57BL/6 mice. Results: PB-deposited MNPs provided an improved adsorbent capacity for Cs removal and reduced toxicity to blood cells compared with those of bulk PB. Conclusion: PB-deposited MNPs could be considered as an alternative of PB-based medicine to reduce the possible hazards caused by high dose of PB intake.

Original languageEnglish
Pages (from-to)3143-3158
Number of pages16
JournalNanomedicine
Volume14
Issue number24
DOIs
StatePublished - 2019

Bibliographical note

Publisher Copyright:
© 2019 Future Medicine Ltd.

Keywords

  • Prussian blue
  • in vivo
  • iron oxide nanoparticles
  • radioactive cesium

Fingerprint

Dive into the research topics of 'In vivo removal of radioactive cesium compound using Prussian blue-deposited iron oxide nanoparticles'. Together they form a unique fingerprint.

Cite this